By many broad measures, the U.S. economy appears to us to be strong and getting stronger, including cycle-high growth in tax ...
TipRanks on MSN
CollPlant’s BioInk Outperforms Matrigel in Technion Study
On October 20, 2025, CollPlant Biotechnologies announced positive results from a study conducted by the Technion – Israel Institute of Technology, which demonstrated that its rhCollagen-based bioink, ...
Life360 stock faces a "Sell" rating despite growth, due to high valuation and stiff competition. Here's what investors need ...
A professor of entrepreneurship from MIT Sloan shares advice for navigating risk, identifying opportunity, and developing ...
The dexamethasone insert effectively treats postoperative inflammation and allergic conjunctivitis, with a favorable safety ...
Designed for home use, Fungabeam features a non-invasive, pain-free treatment mechanism that requires no downtime, medication ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
Sci-fi movies always take us to new worlds or focus on mind-bending concepts based in science. But these sci-fi movies were ...
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...
Q: Several months ago, my right eye began to be bothered by “little critters” flying through the air; when I tried to brush ...
News-Medical.Net on MSN
Microarray platform could help predict immune‐mediated drug‐induced liver injury
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results